Cargando…
A computational method for the identification of candidate drugs for non-small cell lung cancer
Lung cancer causes a large number of deaths per year. Until now, a cure for this disease has not been found or developed. Finding an effective drug through traditional experimental methods invariably costs millions of dollars and takes several years. It is imperative that computational methods be de...
Autores principales: | Chen, Lei, Lu, Jing, Huang, Tao, Cai, Yu-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562320/ https://www.ncbi.nlm.nih.gov/pubmed/28820893 http://dx.doi.org/10.1371/journal.pone.0183411 |
Ejemplares similares
-
Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019) -
Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer
por: Hsu, Jade H.-M., et al.
Publicado: (2019) -
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013) -
Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein Interactions
por: Chen, Lei, et al.
Publicado: (2014) -
Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
por: Zhong, Lei, et al.
Publicado: (2017)